IBEX Ltd·4

Jun 16, 8:30 PM ET

Casteel Julie K 4

4 · IBEX Ltd · Filed Jun 16, 2026

Research Summary

AI-generated summary of this filing

Updated

IBEX Chief Sales/Marketing Officer Julie Casteel Sells 3,600 Shares

What Happened
Julie K. Casteel, IBEX Ltd’s Chief Sales/Marketing Officer, sold 3,600 shares of IBEX common stock on June 11, 2026. The weighted average sale price was $30.61 per share, for total proceeds of approximately $110,183. The filing classifies the transaction as a sale (S).

Key Details

  • Transaction date: June 11, 2026. Form 4 filed: June 16, 2026 (appears to be filed after the typical 2-business-day window).
  • Reported price: weighted average $30.61; individual trade prices ranged from $30.465 to $30.78 (see footnote).
  • Shares sold: 3,600; total proceeds ≈ $110,183.
  • Shares owned after transaction: not specified in the summary provided — see the official Form 4 for post-transaction holdings.
  • Footnote: The sale was executed in multiple trades at prices between $30.465 and $30.78; the reported $30.61 is the weighted average. The filer will provide per-trade details on request.
  • Filing timeliness: Form 4 was filed five days after the transaction date; this appears late relative to normal 2-business-day reporting requirements.

Context
This was an outright sale of common stock (not an option exercise, gift, or award). Sales by executives are often routine (liquidity or diversification) but do not signal company performance on their own. The footnote confirms multiple trades and the use of a weighted-average price; consult the Form 4 for full holdings and any additional disclosures.

Insider Transaction Report

Form 4
Period: 2026-06-11
Casteel Julie K
Chief Sales/Marketing Officer
Transactions
  • Sale

    Common Shares

    [F1]
    2026-06-11$30.61/sh3,600$110,183117,594 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $30.465 to $30.78; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Signature
Lisa Lenstrohm, Attorney-in-Fact|2026-06-16

Documents

1 file
  • 4
    wk-form4_1781656224.xmlPrimary

    FORM 4